BioAdaptives, Inc. (BDPT) shareholders
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
Ownership
Who owns BioAdaptives's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Azuna Health LLC | – | 100.00% | 13D (active) | Apr 18, 2024 |
| James Keener, Azuna Health LLC | – | 100.00% | 13D (active) | Apr 18, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mark P. Frissora | Director | – | – | Nov 4, 2026 |
| Gimhana Sasanka Dissanayake | Director | 125,000 | 0.06% | Dec 3, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gimhana Sasanka Dissanayake Director | Nov 22, 2024 | Buy | +125,000 | $0.09 | $11.25K | 125,000 |
| Barry Epling Director, 10% owner | Oct 1, 2013 | Buy | +41,667 | $0.12 | $5.00K | 10,041,667 |
| Holding Inc. Ferris 10% owner | Oct 1, 2013 | Buy | +41,667 | $0.12 | $5.00K | 10,041,667 |
| Richard Chiang – | Jun 21, 2013 | Sale | −10,000,000 | – | – | 0 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BioAdaptives's stock actually held short. Settlement fails (shares not delivered on time) peaked at 415,347 shares on Oct 9, 2026 over the last 90 days.
See a number that looks wrong?